叶酸和aCD47功能化的脂质纳米颗粒有效地传递mRNA并重塑胰腺瘤微环境
Marta Parés1, Javier Martínez-Latorre2, Vicente Candela-Noguera2
1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|January 7, 2026
概括
新型脂质纳米颗粒 (LNP) 准胰腺癌细胞并增强免疫反应. 这种双重功能化策略为治疗胰腺管道腺癌 (PDAC) 提供了一个有希望的新方法.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种高度侵袭性的癌症,治疗结果不佳.
- 对PDAC的传统疗法显示出有限的疗效,需要创新的治疗策略.
- 目前正在探索多功能平台,以克服PDAC对治疗的抗性.
研究的目的:
- 开发和评估双功能的脂质纳米颗粒 (LNPs) 用于增强的PDAC治疗.
- 研究用于瘤向和免疫调节的LNP介导遗传物质的传递.
- 在PDAC模型中评估与叶酸和抗CD47抗体功能化的LNP的疗效.
主要方法:
- 脂质纳米颗粒 (LNP) 被设计为将DNA等离子体或mRNA输送到PDAC细胞 (Capan-2, PANC-1).
- 用叶酸对受体向和抗CD47抗体来阻止免疫逃避,LNP被表面功能化.
- 进行了体外和体外研究,以评估LNP向,转染效率,细胞和巨分化.
主要成果:
- DNA和mRNA LNP都显示了对PDAC细胞的剂量依赖向,mRNA-LNP显示了更高的转染效率.
- 抗CD47抗体功能化在体外细胞化中显著增加.
- 在体内研究表明,抗CD47功能化的LNP在PDAC异种移植中促进了M1类巨炎症表型.
结论:
- 双功能的LNP通过结合瘤向和免疫系统调节,代表了PDAC治疗的有希望的策略.
- 这种方法增强了细胞吸收,并促进了抗瘤免疫反应.
- 组合式LNP设计为胰腺癌提供了一种新的治疗途径.
相关概念视频
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...